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Although thymus-matured T  cells  are not necessary for in vivo B cell responses to 
a  class  of antigens designated T-independent  (TI) 1 (1,  2),  we wished  to determine 
whether  T  cells  could  influence  the  nature  of the  antibody produced.  It  was  our 
hypothesis that in a TI antigen system in which there is no obligate need for carrier- 
specific helper T  cell triggering signals, T  cells may still exert subtle regulatory effects 
on the B cell antibody response via a distinct population of Ig-specific regulatory cells 
(3-9).  If this  were  indeed  the  case,  such  a  system  might  be  ideal  for studying the 
regulatory effects of Ig-speeific T  cells  independently of carrier-specific T  cells.  The 
characteristics of Ig-specific T  cell interactions with B cells could thus be elucidated 
and compared with the known characteristics of carrier-specific T  cell-B cell interac- 
tions. 
In testing for T  cell influences on B cell responses to TI antigens, our emphasis has 
been to search for possible effects of isotype-specific T  cells.  Our approach has been 
to  determine whether T  cells  could differentially regulate  the  levels  of the  various 
isotypes of antibody made  by the  B  cell  population  responding to  a  subset  of TI 
antigens, designated type 2 TI (TI-2) antigens. These antigens are characterized by 
their lack of polyclonal activating activity and their inability to stimulate B cells from 
neonatal  mice or mice with the CBA/N immune defect  (10).  We here demonstrate 
that the in vivo B cell response to TI-2 antigens can be influenced by T  lymphocytes 
and that this influence is restricted to only some of the Ig isotypes produced, namely 
the IgG2a, and, to a  lesser extent, the IgG2b subclasses. 
Materials and Methods 
Animals.  C57BLI0/ScN nu/nu,  C57BL10/ScN nu/+,  C57BL/KaLwN, and  (CBA/N  × 
C57BL/6)F1 mice were obtained from the Small Animal Section, Division of Research Services, 
National  Institutes  of Health,  Bethesda, Md. Age matched nu/nu and nu/+  male and female 
mice from 2-4 mo of age were used in each experiment. 
Antigens and lmmunizations.  Trinitrophenyl-aminoethylcarbamylmethyl  (TNP-AECM)-Ficoll 
(mol wt  =  400,000; 55  mol  TNP/mol  Ficoll) was  purchased  from  Biosearch  (San  Rafael, 
Calif.).  TNP-AECM-Levan, a  gift of Dr.  Constantin  Bona,  National  Institutes  of Health, 
Bethesda,  Md.,  was prepared as previously described  (1 I). Mice were immunized  with  I0/tg 
antigen  intraperitoneally.  Animals were bled  1 d before immunization and from 5-52 d after 
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immunization.  Pools of serum consisted of equal aliquots taken  from  the individual serum 
samples within a group. Experimental groups consisted of 3-10 mice. 
Selective Enrichment for B  or T  Cell Populations.  To enrich selectively for B cells, nu/ +  and 
nu[nu spleen cell populations were processed in the following manner. Red blood cells and dead 
cells were removed by sequential treatment with lysing  buffer (12) and low ionic strength buffer 
(13). Ceils were then treated with a  10  -~ dilution ofa monoclonal anti-Thy-l.2 antibody (New 
England Nuclear Corp., Boston, Mass.) at a  cell concentration of 5 ×  10S]ml for 45 rain at 
room  temperature,  centrifuged, and  further  incubated  with  a  1:15  dilution of guinea  pig 
complement (C) (Flow Laboratories, Inc., Rockville, Md.) for 45 min at 37°C. The anti-Thy- 
1.2 and C treatment was repeated. Dead cells were removed by reexposure to low ionic strength 
buffer. In a typical experiment, treated cells from nu/nu mice were 78% Ig  +, whereas those from 
nu/+  mice were 82% Ig  + by fluorescence microscopy. 
Spleen cell suspensions were selectively enriched  for T  cells by the method described by 
Mage et al. (14).  After two goat anti-Ig-coated plate passages, the resulting nonadherent cells 
ranged from 1-3% Ig  + and 83-95% Thy-I  +. Cell recovery in nonadherent fraction ranged from 
2O-30%. 
Radioimmunoassayfor Anti-TNP Antibody.  Flexible polyvinyl chloride microtiter plates (Dy- 
natech Laboratories, Inc., Dynatech Corp., Alexandria, Vs.) were coated with 10 #g/ml TNP 
bovine serum albumin (BSA) in phosphate-buffered saline (PBS), pH 7.4  (50 #l/well). TNP- 
BSA was prepared according to the method of Rittenberg and Amkraut (15) and contained 20 
mol of TNP/mol of BSA. After 1 h, plates were washed and coated with 50% fetal calf serum 
(North American Biologicals, Inc., Miami, Fla.) to prevent further nonspecific binding (100 #1/ 
well).  After a  further  1 h  incubation,  the  plates were washed  four times and  50 #1  of the 
appropriate serum diluted in assay buffer (PBS containing 1% BSA +  0.1%  sodium azide + 
0.005 M  disodium ethylenediamine tetraacetate) was added. Anti-TNP serum dilutions were 
incubated in the wells for 3 h  after which the wells were washed six times with PBS, and 50 
#1 of the appropriate 3H-labeled antibody (described below) was added in assay buffer to each 
well. After an additional 3-h incubation, the labeled antibody was removed, the plates were 
washed  13 times with tap water, and the wells were subsequently separated by slicing off the 
top of the microtiter plate. Each well was placed in scintillation fluid and measurements of the 
amount of bound all-labeled antibody were made in a liquid scintillation spectrometer. 
Anti-TNP sera were tested at 8 or 12 twofold dilutions. When log counts per minute bound 
was plotted against the log of serum dilution, a curve with a linear region was obtained. This 
linear region generally included the point at which  1% of added 3H anti-Ig was bound. The 
serum dilution that bound 1% was obtained from the curve and this value was reported as the 
antibody titer. 
Myeloma Proteins used to Purify and Test Specificity of Anti-lsotype Antibodies.  Myeioma proteins 
were purified from ascitic fluids of mice bearing MOPC-21, MOPC-245, UPC-10, CBPC-101, 
MOPC-195S, and BPC-4 plasmacytomas [respective class and allotype designations (16)  are 
IgGl, Igh-4a; IgG1, Igh-4b; IgG2a, Igh-la; IgG2a, Igh-lb; IgG2b, Igh-3a; and IgG2b, Igh-3b] 
by a protein-A Sepharose pH gradient elution technique (17). TEPC-183, MOPC-104E, TEPC- 
15, FLOPC-21, and J606 purified Igh  a myeloma proteins (IgM, IgM, IgA, IgG3, and IgG3, 
respectively) were commercially obtained (Litton Bionetics, Kensington, Md.). Purified mye- 
loma proteins representative of the various isotypes were coupled to cyanogen-bromide-activated 
Sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piseataway, N. J.) and used 
as immunoadsorbents. 
Preparation of Isotype-Specific Antibodies.  Sera from goats (G)  immunized with Fc fragments 
from  MOPC-31C  (Igh-4a), RPC-24B  (Igh-la), CBPC-101  (Igh-lb), or MPC-37  (Igh-3a)  in 
complete Freund's adjuvant  (CFA) and  from rabbits immunized with FLOPC-21  (IgG3) in 
CFA  were  rendered  subclass-specific by  adsorption  on  Sepharose  columns  coupled  with 
myelomas of other isotypes. They were affinity purified using columns containing myeloma 
proteins of the isotype used for immunization. Affinity-purified G  anti-IgM was a  gift of Dr. 
Donna Sieckmann (Naval Medical Research Institute, Bethesda, Md.). Affinity-purified anti- 
bodies at a concentration of 0.5-1.5 mg/ml were tritiated with NaBSH4  (sp act 40-50 C/mM; 
New England Nuclear) by the reductive methylation procedure of Wilder et al. (18). all-labeled 
antibodies had specific activities ranging from 0.5-2.6  ×  106 cpm/#g. They were diluted in P.  K.  A.  MONGINI,  K.  E.  STEIN, AND W.  E,  PAUL 
PBS +  2% BSA  +  0.1% sodium azide, and stored in liquid nitrogen for up to  1 yr without 
noticeable loss of activity. 
Analysis  of Specificity of 3H-labeled Anti-Isotype  Reagents.  Tests  for  specificity were  done by 
measuring the direct binding  of all-labeled reagents to microtiter wells precoated with purified 
myeloma proteins representative of the various isotypes.  In the ease of the IgG1, IgG2a, and 
IgG2b subclasses,  binding to myeloma proteins of both the Igh  a and Igh  h allotypic forms was 
measured.  In addition, inhibition assays  were  performed to compare the ability of various 
isotypic forms of the myeioma proteins to inhibit the binding  of all-labeled antibodies to plate- 
bound myeloma proteins. Through the combination of these approaches, the 3H-labeled anti- 
isotype reagents were ascertained to have specificity for the isotype used for immunization.  The 
G anti-CBPC-101 reagent had specificity for the Igh-1 b allotypic form of IgG2a. 
Comparison of the Binding Efficiencies of the Various 3H-labeled Anti-Isotype Antibodies.  To validate 
the comparison of anti-TNP-antibody  titers of one isotype versus another, the binding efficien- 
ties of the various labeled antibodies were compared in terms of counts per minute bound to a 
known quantity of a given isotype.  Wells were coated with affinity-purified rabbit anti-kappa 
light chain antibody. After washing, saturating nonspeeific binding sites with 1% BSA in assay 
buffer, and washing again, all-labeled myeloma proteins were added to the wells, the percent 
counts per minute bound was determined, and the absolute amount of myeloma (in nanograms) 
bound to  the rabbit anti-kappa coated  wells  was  then calculated. The amount of tritiated 
myeloma protein chosen for addition in these experiments was determined by prior studies to 
be in the linear portion of a  dose-response  curve relating amount of myeloma protein added 
and amount of tritiated anti-Ig antibody bound. Specific  activities of TEPC-183, MOPC-21, 
GBPG-101, MOPG-195S, and FLOPC-21 labeled proteins were 2.0 X 106, 1.7 X 106, 2.0 ×  106, 
1.9  X  106, and  2.5  X  106 cpm//~g,  respectively.  To some of the  wells  that  had  bound aH 
myeloma'protein, all-labeled anti-isotype antibody  (40,000-70,000  cpm)  was  added.  The 
percent all-labeled anti-isotype antibody bound per nanogram of myeloma bound was calcu- 
lated as shown in Table I. 
As seen in the final column, the binding  efficiencies, expressed  as percent anti-isotype counts 
per minute bound per nanogram of bound myeloma varied between 4.6 and 9.4. The fact that 
these binding efficiencies  did not vary by more than a  factor of two enabled us to compare 
binding titers from one subclass to another. 
Results 
Isotypic  Distribution  of Anti-TNP Antibody  in nu/nu  and nu/ +  Mice after Injection with 
TNpoFicoll or TNP-Levan.  To determine whether the presence of a thymus and hence 
mature T lymphocytes had any influence on the relative  amounts of antibody of the 
IgM,  IgG1,  IgG2a,  IgG2b,  and IgG3  isotypes  produced after  immunization of mice 
with a  TI antigen,  congenitally athymic  C57BL10/ScN  nu/nu  and  thymus-bearing 
TABLE  I 
Comparison of Binding Efficiencies of Various all-Labeled Anti-lsotype Antibodies 
Calculated per-  all-labeled myeloma pro-  all-labeled anti-isotype an-  Percent  3H-  cent anti-isotype 
tein added to RaKwell  '~H mye-  tibody added 
(30 ng)  loma  labeled anti-  antibody bound 
bound  isotype anti-  per nanograms 
Designation  Isotype  Specificity  Counts per  body bound  of myeloma 
minute  bound 
ng 
TEPC-183  IgM,x  0.72  GalgM  66,263  4.6  6.4 
MOPC-21  IgGl,r  1.26  GalgG 1  56,500  11.8  9.4 
CBPC-101  IgG2a,~¢  1.23  GaIgG2a  39,482  5.7  4.6 
MOPC- 195S  IgG2b,~c  0.87  GotlgG2b  63,324  4.4  5.1 
FLOPC-21  IgG3,K  0.72  RalgG3  70,832  4.6  6.4 4  T  CELL REGULATION OF ANTIBODY  ISOTYPES 
nu/+  age- and sex-matched mice were injected with  10 #g TNP-Ficoll or 10 #g TNP- 
Levan intraperitoneally.  Sera from mice taken on days 5,and  10 after immunization 
were tested for their titers of anti-TNP antibody of the various Ig isotypes. The data 
in Table II show that both nu/nu and nu/+  mice gave vigorous responses to the two 
TI antigens. In both sets of mice, the IgM titer was highest at day 5, whereas the IgG 
titers  were highest  at  day  10.  Although the IgM, IgG3, and IgG1 responses in both 
nu/nu and nu/+  mice were comparable, the IgG2a response was substantially  higher 
(30-  to  100-fold)  in  thymus-bearing  nu/+  mice  than  in  nu/nu  mice.  The  IgG2b 
response  was  also  somewhat  higher  in  nu/+  mice  but  this  difference  was  not  as 
pronounced as in the IgG2a response. The results suggest that the congenital absence 
of a  thymus can selectively impair the IgG2a and IgG2b responses to TI-2 antigens. 
Comparison of lsotypes of Anti-TNP Antibody Produced by Purified nu/nu and nu/ +  B Cells 
Placed in Identical Environments.  The reduced  IgG2a and  IgG2b responses  to the TI 
antigens TNP-Ficoll  and TNP-Levan in nu/nu  mice vs. nu/+  mice could be due to 
the acute absence of T  cells at the time the B lymphocytes are triggered by antigen. 
An alternative explanation  is that B cells in nu/nu mice are inherently different from 
nu/4-  B  cells  because  of their  retarded  or altered  maturation  in  the  absence  of T 
lymphocytes. 
To  test  for the  latter  possibility,  we assayed  the  TNP-Ficoll-induced  response  of 
purified nu/nu  and nu/+  B  lymphocytes that  had  been  transferred  into genetically 
unresponsive  hosts  (19).  2.5  ×  l0  T anti-Thy-1  +  C-treated,  Ig  +, C57BL/10 nu/nu  or 
nu/+  spleen  cells  were  injected  intravenously  into  (CBA/N  ×  C57BL/6)F1  male 
recipients.  1 d  later the mice were immunized  with TNP-Ficoll and bled on days 5, 
7,  10,  14, and 21  after immunization. The data in Fig.  1 show the kinetics of the IgM, 
IgG1, IgG2b, and IgG2a anti-TNP  antibody responses in recipients and in  (CBA/N 
×  C57BL/6)F1 male mice that had not received cells. Recipients of nu/nu B cells and 
of nu/+  B  cells  had  comparable  anti-TNP  antibody  titers  within  each  isotype, 
including IgG2a and IgG2b. Nu/nu B cell recipients had a slightly lower IgG2a serum 
titer  on  days  5-10  than  nu/+  B  cell  recipients,  but  this  difference  was  less  than 
TABLE II 
Analysis of the Antibody Produced in C57BL/ IO nu/nu and nu/ + Mice after Injection with TI Antigens 
Antigen  Mice tested~  Serum  assayed 
Reciprocal of anti-TNP serum titer* 
IgM  IgG3  IgGl  IgG2b  IgG2a 
TNP-Levan  nu/nu  prebleed  3,500  ND§  10  2  2 
day 5  150,000  ND  40  40  2 
day 10  40,000  ND  800  800  20 
TNP-Levan  nu/+  prebleed  2,200  ND  20  2  2 
day 5  102,000  ND  70  200  200 
day 10  52,000  ND  600  1,600  600 
TNP-Ficoll  nu/nu  day 5  51,200  300  70  3  2 
day l0  15,000  5,000  2,000  120  20 
TNP-Ficoll  nu/+  day 5  20,000  1,500  160  80  160 
day 10  12,800  4,096  2,560  500  2,000 
* Titer expressed as serum dilution at which 1% of added ~H-labeled 
bound. 
:~ Five to seven mice were tested within each group. 
§ ND, not done. 
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DAYS AFTER TNP-FICOLL IMMUNIZATION 
Fro.  1.  Comparison ofanti-TNP-Ficoll responses ofC57BL/10 nu/nu and nu/+ B cells adoptively 
transferred into genetically unresponsive (CBA/N ×  C57BL/6)F] d' recipients. 2.,5 X  107 anti-Thy- 
1 +  C-treated, Ig  +, spleen cells from nu/nu or nu/+  donors were transferred intravenously into 
recipients 1 d  before injection with TNP-Ficotl. Titers are taken of pools of sera from eight mice 
within each group. 
twofold.  As  expected,  unreconstituted  (CBA/N  ×  C57BL/6)F]  male  mice  with  a 
defect determined by the X  chromosomal gene, xid (19), failed to respond to TNP- 
Ficoll. In  fact, the background  anti-TNP-titer in  these mice dropped as successive 
bleeds were taken. 
Thus, the data from this experiment showed that when nu/nu and nu/+  B cells are 
transferred into an  identical milieu containing T  cells, the amounts of the  various 
isotypes of antibody they produce to this TI antigen are comparable. 
Effect  of T  Cell Reconstitution of nu/nu  Mice Shortly before Immunization with  TNP- 
Ficoll.  The above results suggested  that nu/nu  B cells are inherently as capable of 
producing IgG2a antibody to a TI antigen as nu/+  B cells. Thus, the failure of nu/nu 
mice to produce as much IgG2a as nu/+  mice when stimulated by a TI antigen may 
reflect an influence of ancillary T  cell signals during the immune response. Alterna- 
tively, something other than the absence of T  cells in  the nu/nu  environment may 
impair  the  triggering and/or  expansion  of IgG2a  and  IgG2b  B  cell  clones.  In  an 
attempt to distinguish between these possibilities, nu/nu  mice were given 107 C57BL 
T  cells  1 d  before immunization with TNP-FicolI. The serum anti-TNP titer of the 
various isotypes in nu/nu mice, T-cell reconstituted nu/nu  mice, and nu/+  mice was 
assayed on days 5-52 after immunization. The data in Fig. 2 show the effect ofT cell 
reconstitution on the isotypes of anti-TNP antibody produced in nu/nu  mice. Both T  CELL  REGULATION  OF  ANTIBODY  ISOTYPES 
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FIo.  2.  Effect of transferred syngeneic T  cells on  isotypes produced  by C57BL nu/nu mice after 
TNP-Ficoll  immunization. Nu/nu, nu/+, and nu/nu mice reconstituted with  107 C57BL splenic T 
cells 1 d  before TNP-Ficoll immunization were compared in their serum anti-TNP titers at various 
times after immunization with 10/~g TNP-FicoII. Titers are taken from a pool of six mice per group. 
nu/+ and T  cell reconstituted nu/nu mice showed a dramatic elevation in IgG2a anti- 
TNP titers when compared with nu/nu mice over the entire course of the  response. 
The  elevation  of IgG2b  titers  in  T  cell-bearing  mice  was  substantial  but  not  as 
pronounced.  In contrast, no major effect of T  cells on the peak titers of IgM, IgG3, 
and IgG1 antibody was seen.  In both nu/nu and T  cell-bearing mice, the peak IgM 
response  was  found  to  precede  the  peak  IgG response  by several  days.  In  T  cell- 
bearing mice, the peak response of the IgG1, IgG2a, IgG2b, and IgG3 isotypes was 
seen somewhat earlier than  in nu/nu mice.  In addition,  a  finding  in  this and  other 
experiments was that anti-TNP serum titers in T  cell-bearing mice generally tended 
to decline more rapidly than in nu/nu mice. 
In summary, the  two experiments above suggest  that  the  relatively lower IgG2a 
response made by nu/nu mice to the TI antigen TNP-Ficoll is the result of the absence 
of T  lymphocytes during the B cell response rather than the result of a  maturational 
arrest of nu/nu B cells or a suppressive influence present in nu/nu mice. 
To  determine  the  minimal  number of T  lymphocytes that  can  affect  the nu/nu 
IgG2a response to TNP-Ficoll, graded numbers of T  lymphocyte-enriched spleen cells 
were injected into nu/nu mice, and the IgG1 and IgG2a titers were compared on day 
16 after TNP-Ficoll immunization. The data in Fig. 3 show that as few as 1.25 ×  10  + 
T  lymphocytes can cause a significant boost in the IgG2a response of nu/nu recipients 
to TNP-Ficoll. Increasing the number of transferred T  cells did not appear to further 
increase  the response. Although  2.5  ×  106-107  T  cells somewhat elevated  the  IgG1 
response in nu/nu mice, this increase was less than threefold. 
In Table III we have compiled the results from several additional  experiments in 
which the TNP-Ficoll-induced responses of nu/nu and T  cell-reconstituted nu/nu mice 
were  compared.  In  these  experiments,  IgG3,  IgG1,  IgG2b,  and  IgG2a  anti-TNP P.  K. A. MONGINI, K.  E.  STEIN,  AND W.  E.  PAUL 
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FIG. 3.  Effect of number of transferred T cells on the nu/nu IgGl and IgG2a anti-TNP responses 
to TNP-FicolI. Nu/nu mice were injected with no T cells or 0.6-10 X 10  e syngeneic splenic T cells 
1 d before TNP-Ficoll injection. Results are expressed  as the geometric mean of the day-16 serum 
titers with the relative SE of the mean. Each group contained three to six mice. 
TABLE  III 
Comparison of IgG Subclass Anti- TNP Response in TNP-Ficoll Immunized C  5 7  B L / I 0 nu/  nu and T 
Cell-reconstituted C57BL/10 Mice 
Experi-  Mice tested 
ment No. 
Reciprocal anti-TNP titers in serum 14-20 d 
after TNP-Ficoll immunization 
IgG3  IgGl  IgG2b  IgG2a 
1  nu/nu  8,200  2,500  200  30 
nu/nu + 107 C57BL/Ka T cells  12,000  5,100  800  1,280 
2  nu/nu  32,000  12,800  2,500  20 
nu/nu + 2.5 ×  107 C57BL/10 T cells  50,000  10,000  20,000  4,000 
3  nu/nu  42,000  28,000  5,120  500 
nu/nu + 2.5 ×  10  e C57BL/Ka T ceils  30,000  36,000  12,000  4,000 
4  nu/nu  25,600  12,800  1,800  200 
nu/nu + 2.5 ×  106 C57BL/Ka T cells  12,000  8,000  2,500  2,280 
antibody titers were  determined on  sera taken  14-16  d  after immunization.  These 
data  reinforce  the  observation  that  IgG3  and  IgG1  responses  to  TNP-Ficoll  are 
relatively unaffected by T  lymphocytes, whereas the IgG2a and IgG2b responses are 
positively influenced  by the presence of T  cells. In every case IgG2a responses  are 
more dramatically affected than IgG2b responses. 
In most experiments C57BL/KaLwN  T  cells were transferred into C57BL10/ScN 
nu/nu  mice.  Because  C57BL/KaLwN  and  C57BL/10  sublines  have  some  minor 
differences, the possibility existed that  this selective enhancement  of IgG2 antibody 
was the result of a  minor allogeneic effect. That this is not the case is demonstrated in 
experiment 2 in which the transfer of C57BL10/ScN T  cells has the same effect. T  CELL  REGULATION  OF  ANTIBODY  ISOTYPES 
A trend that becomes obvious when comparing the titers of the various isotypes in 
the nu/nu reponse to TNP-Ficoll is that  the strength of the response of the gamma 
isotypes is in the following order: IgG3 >  IgG 1 >  IgG2b >  IgG2a. The presence of T 
cells, however, shifts this isotypic distribution so that higher levels of IgG2b and IgG2a 
are produced and this hierarchy in response becomes less pronounced. The validity of 
comparing the radioimmunoassay titers of the diverse isotypes has been discussed in 
Materials and Methods. 
Discussion 
It is now clear that certain antigens, designated TI antigens, can stimulate B cells 
to  proliferate and  to  differentiate into  antibody-producing cells  in  the  absence of 
detectable ancillary T  cell signals (1, 2). This study has shown that B cells in athymic 
nude mice can be triggered by TNP-Ficoll and TNP-Levan to secrete not only IgM 
but also IgG 1, IgG2a, IgG2b, and IgG3 antibody. Thus B cells can, in an environment 
containing few, if any, thymus-matured T  lymphocytes, produce antibody of many 
isotypes.  Interestingly,  the  relative  amount  of anti-TNP  antibody  of the  various 
isotypic classes produced by nude mice immunized with TNP-Ficoll was  found to 
correlate directly with the 5' to 3' heavy chain constant region gene order in the mouse 
(20).  Thus,  in  a  series  of experiments, we  found  that  the  peak  titers  of anti-TNP 
antibodies were in the following order: IgM >  IgG3 >  IgG1 >  IgG2b >  IgG2a. It is 
unlikely that differential catabolism of the various Ig isotypes is responsible for this 
heirarchy in serum titers. Comparisons of the known catabolic rates of IgM,  IgG1, 
IgG2b, and IgG2a (140, 17, 25, and  13% per day, respectively) (21) with the maximal 
anti-TNP titers of each isotype measured fail to show any correlations. This observa- 
tion raises the provocative possibility that the frequency of responding cells of a given 
isotype is dependent on the distance of the particular constant region gene from the 
site(s) 5' to the # gene reported to be involved in gene switching (22).2 Whether B cell 
responses to TI-2 antigens other than TNP-Ficoll and TNP-Levan will  also reflect 
this gene order, and whether it is a  feature of all  inbred strains,  is currently under 
investigation. 
Our predominant interest has been to determine whether these levels of antibody 
of the  various  isotypes might  be  influenced by T  lymphocytes and,  if such T  cell 
regulation  exists,  what  mechanisms  might  be  involved.  Our  data  indicate  that 
unprimed T  lymphocytes can in fact influence the distribution of isotypes produced 
to TI antigens of the TI-2 class.  A positive T cell influence was seen predominantly on 
IgG2a, an isotype that was poorly produced in athymic nu/nu mice. A slight effect of 
T  cells on IgG2b antibody production was  also observed. This selective regulatory 
effect of T  cells on IgG2a and IgG2b antibody production did not increase the levels 
of these isotypes beyond the levels of IgM, IgG3, and IgG 1. This is in agreement with 
the  observation  of Slack  et  al.  (23)  that  the  IgG3  and  IgG1  plaque-forming  cell 
responses of normal thymus-bearing mice to TNP-Ficoll are significantly greater than 
the combined IgG2a and IgG2b plaque-forming cell responses. 
We have considered two major explanations for the preferential helper T  cell effect 
on IgG2 production. (a) In normal animals, T  cells may exist that can interact with 
IgG2a-positive B cells, perhaps by recognizing B cell surface IgG2a. This T  cell-B cell 
2 Davis, M., S. Kim, and L. Hood. DNA sequences mediating class switching in alpha immunoglobulin 
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interaction mediated through B cell surface IgG2a may cause preferential expansion 
of IgG2a clones. The small amount of T  cell-expanded IgG2b production could be 
explained by cross-reactivity of IgG2a and  IgG2b determinants or alternatively by 
the existence of a small population of IgG2b-specific TH cells.  It should be noted that 
this explanation  for the  increased  IgG2a  responses seen  in  the  presence of T  cells 
requires  that  the  responding  B  cells  have  undergone the  IgM  to  IgG switch,  and 
express  membrane  IgG2a  before  the  action  of these  T  cells.  (b)  T  cells  might, 
alternatively, induce greater Ig heavy chain  gene switching in  virgin B  cell clones 
responding to TNP-FicolI. Thus, additional activation signals given by T  cells at the 
time of B cell triggering may promote the process of gene switching in such a way as 
to make it more likely that distal constant region genes, such as IgG2a, are expressed. 
The specificity of T  cells that might deliver such signals is not obvious. It is unlikely 
that they are Ficoll-specific, in that Ficoll is not considered an effective immunogen. 
DNP hapten-specific helper T  cells, on the other hand, have been demonstrated in 
primed T  cell populations (24). Although the effective T  cell populations used here 
have not been primed, we cannot exclude the possibility that they have such specificity 
for TNP. Finally, the ancillary T  cells may have specificity for a membrane-bound B 
cell determinant, perhaps Lyb3, Lyb5, Lyb7, or Ia (25-27). 
We are not yet able to distinguish between these two major mechanisms by which 
T  cells may enhance IgG2a production by B cells.  It is clearly of interest to determine 
the specificity of the effector T  cell population and to determine whether it interacts 
with  B  cells  to  result  in  an  increased  number  of IgG2a-positive clones  or  simply 
increased IgG2a production from already differentiated clones. 
When investigating the response kinetics of the various isotypes in T  cell-bearing 
and athymic mice, several observations were made with regard to the rapidity and 
the prolongation of the response. First, in mice bearing T  cells, the peak IgG1, IgG3, 
IgG2b, as well as IgG2a, antibody titers were generally seen earlier than in nude mice. 
This  suggests  that  T  cells  may subtly  influence the  rate  of differentiation to  IgG 
production.  It  should  be  noted  again  that,  in  terms  of magnitude  of the  overall 
response, only the IgG2a and IgG2b isotypes were affected by T  cells.  Because IgM 
production was not assayed prior to day 5 after immunization, a time of peak serum 
IgM levels, we cannot determine whether T  cells accelerated the IgM response. It has 
recently been shown that the in vitro IgM anti-TNP response of mouse spleen cells to 
TNP-Ficoll can be markedly diminished by vigorous depletion ofT lymphocytes (28). 
It is conceivable that this effect is related to the capacity oft  cells to accelerate B cell 
antibody production. 
In addition to hastening the production of IgG after TNP-Ficoll immunization, the 
presence of T  cells also caused a  more pronounced fall in antibody titer after peak 
production had been achieved. Recent studies (29) have suggested that this might be 
the  result  of T  cell-dependent  anti-idiotype-induced regulation  of the  TNP-Ficoll 
response. 
In  numerous  experiments  in  which  the  kinetics  of the  response  of the  various 
isotypes was investigated, peak titers of each isotype were generally seen at the same 
time.  This  suggests  that  in  the  differentiation  of a  TNP-Ficoll  responsive  B  cell, 
sequential switching of a  given B cell through  IgM ~  IgG3 ~  IgG1 ~  IgG2b --0 
IgG2a  stages  is  unlikely.  Instead  it  suggests  that,  if an  antigen-induced  switching 
event  does take  place, a  more likely used  differentiation pathway is  one in  which 10  T  CELL REGULATION OF ANTIBODY ISOTYPES 
progeny of a  given B cell clone each diverge and switch from an IgM-positive stage 
to an IgG3, IgG1, IgG2b, or IgG2a-positive stage at approximately the same time. 
These experiments  have  suggested  that  the  Ig  constant  region  gene order  may 
inherently control the amount of antibody of the various isotypes produced when B 
lymphocytes are stimulated by TI-2 antigens.  Furthermore, our results suggest that 
the isotypic distribution is influenced by additional signals given by T  lymphocytes. 
It is possible that, in B cell responses to every type of antigen, the deviation from a 
heirarchic  isotypic  response  reflecting gene  order  is  dependent  on  the  nature  of 
additional signals that a responding virgin B cell received, i.e., strong or weak T  cell 
signals or strong or weak polyclonal activating signals inherent to the antigen. The 
delivery of  strong signals to B lymphocytes may cause an increase in heavy chain gene 
switching.  Finally, helper T  cells that recognize specific isotypic determinants on B 
cell progeny that have switched their membrane isotype could even further expand 
the production of certain isotypes over that of others. The combined effects of these 
various  antigenic  and  cellular signals  would  then  create  the  isotypic distribution 
characteristic of a B cell response to a given antigen. 
Summary 
The effect of T  lymphocytes on the IgM, IgG3, IgG I, IgG2b, and IgG2a responses 
of B  lymphocytes to the type-2 T-independent antigens,  trinitrophenylated (TNP)- 
Ficoll, and TNP-Levan, was investigated. T  cell-bearing nu/+  mice were found to 
produce  substantially  higher  IgG2  serum  anti-TNP  antibody  than  their  athymic 
counterparts, with nu/nu and nu/+ IgG2a titers exhibiting more disparity than nu/nu 
and  nu/+  IgG2b  titers.  The  IgM,  IgG3,  and  IgG1  anti-TNP  levels in  nu/nu and 
nu/+  mice were indistinguishable.  By cell transfer experiments, it was determined 
that this variance in nude and heterozygote IgG2 responses could not be explained by 
B cell differences between the two strains or by suppressive effects on IgG2 production 
within nu/nu mice. Rather, the difference was shown to be the result of the absence of 
T  cells at the time B cells were responding to antigen. In the absence of T  cells, the 
strength of the nu/nu anti-TNP antibody response was found to be in the following 
order: IgM >  IgG3 >  IgG1 >  IgG2b >  IgG2a, a heirarchy identical with the recently 
proposed  heavy  chain  gene  order.  The  possibilities  that  T  cells  influence  IgG2 
production  via  their specific recognition of IgG2-bearing B  cells or via signals  to 
increase heavy chain switching of responding B cell clones are discussed. 
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